openPR Logo
Press release

Biosimilars Market Report, Size, Share, Insights 2024-2031 - Amgen Inc, Novartis AG & Pfizer Inc.

09-06-2024 03:05 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Biosimilars Market || 2024-2031

Biosimilars Market || 2024-2031

The global biosimilars market, valued at USD 30.1 billion in 2022, is poised for significant expansion, with projections estimating it will reach USD 76.7 billion by 2031. This growth represents a robust CAGR of 12.8% from 2024 to 2031.

Biosimilars are biological products designed to be highly similar to already approved reference biologics, demonstrating no significant clinical differences in terms of efficacy, safety, and quality. They are used to treat a range of conditions across various therapeutic areas, including rheumatology, oncology, hematology, gastroenterology, and endocrinology.

Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/biosimilars-market

Market Trends:

The rising number of biosimilar drug approvals by the FDA drives global biosimilar market growth.

The global biosimilars market is anticipated to grow significantly, driven by the increase in approved biosimilars due to enhanced FDA review processes and advancements in manufacturing and development techniques. For instance, in March 2022, Amneal Pharmaceuticals, Inc. received FDA approval for filgrastim-ayow, a biosimilar to Neupogen, which will be marketed under the RELEUKO brand. This approval reflects the growing familiarity of manufacturers with the complex regulatory and legal frameworks for biosimilars, leading to a rise in biosimilar submissions.

However, the development of biosimilars is hampered by high costs and long timelines. Producing a biosimilar can take 7 to 8 years and cost between $100 million and $300 million, which poses a significant barrier to market growth, particularly in lower-income regions. The substantial research and development expenses contribute to the slow acceptance and proliferation of biosimilars, affecting overall market expansion.

Market Segmentation:

By Product: Monoclonal Antibodies,Recombinant Human Growth Hormone (rhGH), Insulin, Anti-coagulants, Erythropoietin, Fusion Proteins, Granulocyte Colony Stimulating Factor, Follitropin.

By Technology: Recombinant DNA Technology (rDNA technology), Monoclonal Antibodies (MAb) Technology.

By Application: Oncology, Chronic and Immune Diseases, Infectious Diseases, Growth Hormone Deficiency, Blood Disorders.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/biosimilars-market

Competitive Landscape:

• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• Pfizer Inc.
• Biocon
• Samsung Bioepis
• Mylan NV
• Celltrion
• Biogen
• Intas Pharmaceutical Ltd

Regional Analysis:

The Biosimilars Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Biosimilars Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Key Developments:

In May 2023, Gulf Pharmaceutical Industries PJSC (Julphar), a major pharmaceutical producer in the Middle East and Africa, announced a strategic licensing agreement with Sunshine Lake Pharma, a Chinese pharmaceutical company. This partnership will position Julphar as the first manufacturer of modern insulin biosimilars in the MENA region, marking a significant milestone in the regional pharmaceutical industry.

Related Reports:

Occupational Medicines Market: https://datamintelligence.com/research-report/occupational-medicines-market

Collagen and Gelatin Market: https://datamintelligence.com/research-report/collagen-and-gelatin-market

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimilars Market Report, Size, Share, Insights 2024-2031 - Amgen Inc, Novartis AG & Pfizer Inc. here

News-ID: 3648121 • Views:

More Releases from DataM Intelligence 4market Research LLP

Bubble Tea Market is projected to grow at a CAGR of 7.5% during the forecast period from 2024 to 2031 - The Bubble Tea Company, Bobabox Limited & Cuppotee.
Bubble Tea Market is projected to grow at a CAGR of 7.5% during the forecast per …
The Global Bubble Tea Market was valued at US$ 2,984 million in 2022 and is expected to experience significant growth, reaching US$ 5,322 million by 2031. The market is projected to grow at a CAGR of 7.5% during the forecast period from 2024 to 2031. Bubble tea, also known as boba tea or pearl milk tea, is a Taiwanese tea-based beverage that typically consists of brewed tea, milk or fruit flavorings,
Polyurea Coatings Market Report Analysis, Research Studies - 2024-2031 - Specialty Products, Inc, Nukote Coating Systems & Marvel Coatings.
Polyurea Coatings Market Report Analysis, Research Studies - 2024-2031 - Special …
The global polyurea coatings market is projected to grow at a CAGR of 1.9% from 2024 to 2031. Polyurea coatings are a type of protective and versatile coating made from a reaction between isocyanates and polyamines. They are known for their rapid curing time, high durability, and resistance to chemicals, abrasion, and weathering. Polyurea coatings are often used in a variety of applications, including industrial, commercial, and residential settings, to provide
Sustainable Aviation Fuel Report Analysis, Research Studies - 2024-2031 - Neste, Fulcrum BioEnergy & LanzaTech .
Sustainable Aviation Fuel Report Analysis, Research Studies - 2024-2031 - Neste, …
The Global Sustainable Aviation Fuel Market was valued at USD 320.8 million in 2023 and is projected to experience significant growth, reaching USD 3,581.0 million by 2031. This represents a robust CAGR of 35.2% during the forecast period 2024-2031. Sustainable Aviation Fuel (SAF) is a type of aviation fuel derived from sustainable sources that aims to reduce the carbon footprint associated with traditional jet fuels. Unlike conventional fossil-based jet fuels, SAF
𝗔𝐧𝐠𝐢𝐨𝐩𝐥𝐚𝐬𝐭𝐲 𝗕𝐚𝐥𝐥𝐨𝐨𝐧𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭, 𝐒𝐢𝐳𝐞, 𝐒𝐡𝐚𝐫𝐞 & 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 - 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟏 - 𝐁𝐨𝐬𝐭
𝗔𝐧𝐠𝐢𝐨𝐩𝐥𝐚𝐬𝐭𝐲 𝗕𝐚𝐥𝐥𝐨𝐨𝐧𝐬 …
The global angioplasty balloons market was valued at USD 2.2 billion in 2023 and is anticipated to grow significantly, reaching USD 2.9 billion by 2031. During the forecast period of 2024-2031, the market is projected to grow at a compound annual growth rate (CAGR) of 3.5%. Angioplasty balloons are essential devices utilized in percutaneous transluminal angioplasty (PTA), a procedure primarily used to address cardiovascular conditions, particularly coronary artery disease. These balloons

All 5 Releases


More Releases for Pharma

Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Report
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986 Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications